170 results
8-K
EX-99.1
NUWE
Nuwellis Inc
30 Apr 24
Nuwellis Announces Pricing of $2.7 Million Public Offering
6:25pm
related to the offering, those risks associated with our ability to execute on our commercialization strategy, the possibility that we may be unable
8-K
EX-99.2
NUWE
Nuwellis Inc
30 Apr 24
Nuwellis Announces Pricing of $2.7 Million Public Offering
6:25pm
of customary closing conditions related to the offering, those risks associated with our ability to execute on our commercialization strategy, the possibility
424B4
NUWE
Nuwellis Inc
29 Apr 24
Prospectus supplement with pricing info
4:58pm
, including our clinical and product development strategy,
or our competitors;
regulatory developments, disclosure regarding completed, ongoing
8-K
03q11pj
26 Mar 24
Other Events
5:00pm
8-K
EX-99.1
pgf76ok6fwwwxm1a 5w
6 Mar 24
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
12:02pm
8-K
EX-99.1
z0758hkv04 gotlhk
6 Feb 24
Other Events
9:07am
8-K/A
EX-99.1
4dsrci6jpgw8
9 Jan 24
Regulation FD Disclosure
5:30pm
8-K
EX-99.1
u2mljk46gui7 j5
8 Jan 24
Regulation FD Disclosure
9:24am
8-K
EX-99.1
mawptym
7 Nov 23
Nuwellis, Inc. Announces Third Quarter 2023 Financial Results
8:15am
8-K
EX-99.1
rr30tz023ocx4rx
1 Nov 23
Nuwellis Announces Board of Directors Transition
4:15pm
8-K
EX-99.1
c9t0u kqeq1a6nqhybid
17 Oct 23
Nuwellis Announces Pricing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
4:30pm
8-K
EX-99.2
jng0608mb6m1
17 Oct 23
Nuwellis Announces Pricing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
4:30pm